Dealing with a new diagnosis or confusing lab numbers? Talk with people who have been there. See how members lowered A1C, timed Metformin ER, and optimized thyroid labs—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Diabetes, Thyroid & A1C Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Diabetes, Thyroid & A1C Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data
← All Conditions (3,135) / Thyroid, Adrenal & Endocrine Disorders

Thyroid, Adrenal & Endocrine Disorders (112 Condition Guides)

Hypothyroidism, Hashimoto thyroiditis, Graves disease, parathyroid, adrenal, and pituitary disorders.

Interactive MyChart Lab & Cuff Translator • Lab Bell-Curve “Normal” vs. Physiological Optimal

Why Your Portal Says “Normal” When You Still Feel Awful: Enter Your Number

Quest and LabCorp “Normal” ranges are 95% population bell curves—not physiological optimums. Select a marker and type your result below:

3-Zone Clinical Cutoff Audit • Serum Ferritin (Iron Storage)

18 ng/mL = Marked "Normal" by Lab, Yet Clinically Depleted (< 30–50 ng/mL)

Default Sample: 18 ng/mL
Zone 1 • Clinical Cutoff
< 15 ng/mL • Overt Deficiency
< 15 ng/mL (Absolute Depletion)
Zone 2 • Portal “Normal” Gray Zone
15–49 ng/mL • "Normal" Yet Depleted
15–150 ng/mL (Quest/LabCorp Bell Curve)
Zone 3 • Physiological Optimal
50–100 ng/mL • Clinical Optimal
50–100 ng/mL (Physiological Optimal)
What This Number Means in Plain English

Commercial labs only flag Ferritin below 15 ng/mL, but clinical trials confirm fatigue, restless legs, diffuse telogen hair shedding, and impaired T4-to-T3 thyroid conversion begin whenever Ferritin drops below 30–50 ng/mL.

Action Plan: Take 25–28 mg elemental Iron Bisglycinate on alternate mornings (Mon/Wed/Fri) with Vitamin C to bypass the 24-hour hepcidin block, then re-test in 8–12 weeks.

⚠ Lab Assay & Cuff False-Alarm Check

Acute inflammation, viral illness, or fatty liver artificially elevates Ferritin (it is an acute-phase reactant). Always pair Ferritin with Fasting Transferrin Saturation (TSAT) and hs-CRP.

Specialty Directory

Thyroid, Adrenal & Endocrine Disorders Guides (112)

Clear Filter × Page 2 of 4

Empty sella syndrome

Empty sella syndrome (ICD-10-CM E23.6) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Fanconi syndrome

Fanconi syndrome (ICD-10-CM E72.09) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Fructose intolerance

Fructose intolerance (ICD-10-CM E74.12) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Galactosemia

Galactosemia (ICD-10-CM E74.21) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Gauchers disease

Gauchers disease (ICD-10-CM E75.22) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Goiter - multinodular

Also called: Nodule • Nodular • Multinodular

Goiter - multinodular (ICD-10-CM E04.2) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Graves disease

Graves disease (ICD-10-CM E05.00) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

HGPRT deficiency

HGPRT deficiency (ICD-10-CM E79.1) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Hartnup disease

Hartnup disease—coded clinically as E72.02 across Thyroid & Endocrine guidelines—combines high-resolution endocrine ultrasonography [Hartnup disease E72.02] with structured follow-up of Morning Serum Cortisol in Hartnup disease (E72.02: (8 AM)) (10 – 18 mcg/dL (E72.02)).

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Hashimoto thyroiditis

Hashimoto thyroiditis (ICD-10-CM E06.3) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Hemosiderosis

Hemosiderosis (ICD-10-CM E83.19) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Homocystinuria

Homocystinuria (ICD-10-CM E72.11) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Hyperaldosteronism

Hyperaldosteronism (ICD-10-CM E26.9) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Hyperfunction of pituitary gland

Hyperfunction of pituitary gland (ICD-10-CM E22.9) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Hyperparathyroidism

Hyperparathyroidism (ICD-10-CM E21.3) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Hyperthyroidism

Also called: Overactive thyroid

Hyperthyroidism, or overactive thyroid, happens when your thyroid gland makes more thyroid hormones than your body needs. Your thyroid is a small, butterfly-shaped gland in the front of your neck. It makes hormones that control the way the body uses energy. These hormones affect nearly every organ in your body and control many of your body's most important functions. For example, they affect your breathing, heart rate, weight, digestion, and moods. If not treated, hyperthyroidism can cause serious problems with your heart, bones, muscles, menstrual cycle, and fertility. But there are treatments that can help.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Hypoaldosteronism

Hypoaldosteronism (ICD-10-CM E27.40) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Hypoparathyroidism

Hypoparathyroidism (ICD-10-CM E20.9) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Hypothyroidism

Also called: Underactive thyroid

Hypothyroidism, or underactive thyroid, happens when your thyroid gland doesn't make enough thyroid hormones to meet your body's needs. Your thyroid is a small, butterfly-shaped gland in the front of your neck. It makes hormones that control the way the body uses energy. These hormones affect nearly every organ in your body and control many of your body's most important functions. For example, they affect your breathing, heart rate, weight, digestion, and moods. Without enough thyroid hormones, many of your body's functions slow down. But there are treatments that can help. What causes hypothyroidism? Hypothyroidism has several causes.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Idiopathic hypoparathyroidism

Idiopathic hypoparathyroidism (ICD-10-CM E20.0) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Iodine-deficiency related (endemic) goiter

Iodine-deficiency related (endemic) goiter (ICD-10-CM E01.2) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Iodine-deficiency related multinodular (endemic) goiter

Iodine-deficiency related multinodular (endemic) goiter—coded clinically as E01.1 across Thyroid & Endocrine guidelines—combines high-resolution endocrine ultrasonography [Iodine-deficiency related multinodular (endemic) goiter E01.1] with structured follow-up of Morning Serum Cortisol in Iodine-deficiency related multinodular (endemic) goiter (E01.1: (8 AM)) (10 – 18 mcg/dL (E01.1)).

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Keratosis - inverted follicular

Also called: Flipped • Inverted • Inversion

Keratosis - inverted follicular (ICD-10-CM E50.8) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Magnesium - high

Also called: Hypermagnesemia

Magnesium - high—coded clinically as E83.41 across Thyroid & Endocrine guidelines—combines electrolyte-mineral balance monitoring [Magnesium - high E83.41] with structured follow-up of Thyroid-Stimulating Hormone (TSH) [Magnesium - high E83.41] (0.8 – 2.5 mIU/L (E83.41)).

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Magnesium - low

Also called: Hypomagnesemia

Magnesium - low (ICD-10-CM E83.42) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Maple syrup urine disease (MSUD)

Also called: Water • Amniotic

Maple syrup urine disease (MSUD) (ICD-10-CM E71.0) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Milk-Alkali syndrome

Milk-Alkali syndrome (ICD-10-CM E83.52) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Mucopolysaccharidosis

Mucopolysaccharidosis (ICD-10-CM E76.3) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Myxedema

Myxedema (ICD-10-CM E03.9) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Myxedema coma

Myxedema coma (ICD-10-CM E03.5) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Nelson's syndrome

Nelson's syndrome (ICD-10-CM E24.1) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Nontoxic diffuse goiter

Nontoxic diffuse goiter (ICD-10-CM E04.0) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Nontoxic goiter

Nontoxic goiter (ICD-10-CM E04.9) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Nontoxic multinodular goiter

Nontoxic multinodular goiter (ICD-10-CM E04.2) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Osteitis fibrosa

Osteitis fibrosa (ICD-10-CM E21.0) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy
Connected Clinical Ecosystem • Medications, Supplements & Specialists

Go From Diagnosis to Treatment: Connected Flagship Guides

Prescription Medications (/meds)

FDA DailyMed & NADAC Cash Price Guides

Decode tablet imprints, IR vs. ER stomach side effects, Rule-of-6 dose response curves, and $3–$9 generic cash prices.

Dietary Supplements (/supplements)

NIH ODS & Elemental Label Math Guides

Separate human RCT outcomes from social media hype—with elemental vs. compound weight decoders and serum 25(OH)D targets.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Compare U.S. specialists by real CMS Medicare Part B procedure volume, verified Google patient reviews, and accepted PPO/Medicare plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

Which diagnostic lab ranges and guidelines govern Thyroid, Adrenal & Endocrine Disorders on dotMD.com?

dotMD.com maps Thyroid, Adrenal & Endocrine Disorders against ADA, ACC/AHA, USPSTF, and Endocrine Society diagnostic criteria, contrasting broad 95% portal reference intervals with optimal clinical targets. Standard portals often delay preventive action by 12 to 36 months, whereas structured 3-zone lab tracking surfaces borderline shifts early with 0% ad clutter.

Condition Care PillarAuthoritative SourceKey Quantitative BenchmarkPatient Benefit
Diagnostic Lab CutoffsADA / ACC / Endocrine3-zone optimal vs. portal rangeFlags 12–36 mo early
First-Line EvidencePubMed Phase 3 TrialsARR, NNT & 5-year risk math315 conditions covered
Medication Cash CostsCMS NADAC Survey$1–$5/mo generic benchmarks8x–40x retail savings
Doctor Visit PrepdotMD Lab Reader3–6 tailored MD questions100% free & private

How should patients prepare lab numbers and questions for a Thyroid, Adrenal & Endocrine Disorders visit?

dotMD.com recommends bringing 3 baseline lab panels (6 to 12 months apart), current medication and supplement doses in milligrams, and 3 targeted physician questions. Auditing treatment options by Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT) clarifies real 5-year benefit in under 5 mins.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee